NPPA fixes ceiling price of 15 scheduled formulations, Details
New Delhi: In accordance with the price revision as per the annual wholesale price index (WPI) of 12.1218%, through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Ministry of Chemicals and Fertilizers, the Government of India has fixed the ceiling price of 15 scheduled formulations under the National List of...
New Delhi: In accordance with the price revision as per the annual wholesale price index (WPI) of 12.1218%, through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Ministry of Chemicals and Fertilizers, the Government of India has fixed the ceiling price of 15 scheduled formulations under the National List of Essential Medicines (NLEM), 2022.
The list of 15 scheduled formulations includes Amoxicillin, Azithromycin, Azathioprine, Benzoyl peroxide, Cefuroxime, Cholecalciferol, Dexamethasone, Ivermectin, Linezolid, Metoprolol, Vancomycin and others.
This came in line with the decision of the 111th Authority meeting date March 29th 2023, where the ceiling price fixation of scheduled formulations under the Drug (Price Control) Order 2013 (National List Of Essential Medicine 2022) was discussed.
The notice declared that in exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May 2013 and S.O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the ceiling prices exclusive of goods and services tax applicable, if any, as specified in column (5) and increased by Wholesale Price Index (WPI) of 12.1218% under para 16 (1) of DPCO 2013, with effect from 1.04.2023 as specified in column (6)of the table in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
Name of the
Dosage form and strength
Powder for Injection 250 mg
Powder for Injection 500 mg
Sachet/Granuels/Powder 60000 IU
Tablet 4 mg
The notification further added:
Doctor of Pharmacy
Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.